← Eichor
Condition: Acute Radiation Dermatitis Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Acute Radiation Dermatitis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Akkermansia Muciniphila (AKK) for Radiation-Induced Skin Injury
Phase 1 · 2 location(s) · West China Hospital · NCT07635277
Mepilex Lite Dressings for the Treatment of Acute Radiation Dermatitis of Anal Canal Skin
NA · 1 location(s) · Qianfoshan Hospital · NCT06837831
Topical Chlorhexidine Spray for the Prevention of Acute Radiation Dermatitis in Patients With Nasopharyngeal Carcinoma:
Phase 3 · 1 location(s) · Jiangxi Provincial Cancer Hospital · NCT07559877
Bacterial Cellulose-monolaurin Hydrogel for Acute Radiation Dermatitis
NA · 1 location(s) · University of the Philippines · NCT05079763
Prospective Assessment of Acute Skin Toxicities in Breast Cancer Patients Undergoing Retreatment with 40 Gy in 15 Fracti
Phase N/A · 1 location(s) · Sunnybrook Health Sciences Centre · NCT06729814
Taurine's Therapeutic Effect on Acute Radiation-induced Oral Mucositis and Dermatitis
Phase 2 · 1 location(s) · Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao · NCT07029178
Polarized Light Therapy for Radiation Dermatitis in Breast Cancer
NA · 1 location(s) · Beni-Suef University · NCT07600957
StrataXRT vs Standard Clinical Practice for the Prevention of Acute Dermatitis in Head and Neck Cancers Patients
NA · 1 location(s) · National University Hospital, Singapore · NCT03394417
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.